Semler Scientific, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
Weiss Asset Management LP, WAM GP LLC, and Andrew M. Weiss report no beneficial ownership of Semler Scientific, Inc. common stock as of March 31, 2026.
Weiss Asset Management LP, WAM GP LLC, and Andrew M. Weiss have reported a 5.2% beneficial ownership stake in Semler Scientific, Inc. as of December 31, 2025.
Ridgeback Capital Investments L.P., Ridgeback Capital Investments LLC, and Ridgeback Capital Management LLC have reported a complete divestment of their beneficial ownership in Semler Scientific, Inc.
A group of affiliated entities, including Capital Ventures International and Susquehanna Advisors Group, Inc., has reduced its beneficial ownership in Semler Scientific, Inc. to 2.6% of common stock.
Capital International Investors has reported a 2.6% beneficial ownership stake in Semler Scientific, Inc. as of September 30, 2025.
BlackRock, Inc. has reported a 5.7% passive ownership stake in Semler Scientific, Inc., holding 858,705 shares of common stock.
A group of affiliated entities, including Capital Ventures International and Susquehanna Advisors Group, Inc., reported a collective beneficial ownership of 5.7% in Semler Scientific, Inc.
Citadel Securities and affiliated entities, including Kenneth Griffin, have disclosed a passive beneficial ownership of 5.1% in Semler Scientific, Inc.
A group of affiliated entities, including Capital Ventures International and Susquehanna Advisors Group, Inc., disclosed a collective 4.4% beneficial ownership in Semler Scientific, Inc.
Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have disclosed a 5.8% beneficial ownership stake in Semler Scientific, Inc.
SCHEDULE 13G/A: BlackRock Amends Semler Scientific Stake Disclosure to 4.3%
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.3% beneficial ownership stake in Semler Scientific Inc. common stock.
Ridgeback Capital Investments L.P., Ridgeback Capital Investments LLC, and Ridgeback Capital Management LLC have jointly disclosed a beneficial ownership of 6.9% in Semler Scientific, Inc., totaling 976,112 shares.
SCHEDULE 13G: BlackRock Discloses 5.2% Stake in Semler Scientific Inc.
BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.2% of Semler Scientific Inc.'s common stock as of March 31, 2025.
Capital International Investors has filed a Schedule 13G, revealing a 6.2% beneficial ownership stake in Semler Scientific, Inc. as of December 31, 2024.
SCHEDULE 13G/A: Susquehanna Affiliates Disclose 5.9% Stake in Semler Scientific
A group of affiliated entities, including Capital Ventures International and Susquehanna Advisors Group, Inc., have disclosed a collective beneficial ownership of 5.9% in Semler Scientific, Inc.'s common stock.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 3.6% of Semler Scientific, Inc.'s common stock as of December 31, 2024.